ZyVersa Therapeutics (ZVSA) Institutional Ownership → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free ZVSA Stock Alerts $4.99 -1.09 (-17.93%) (As of 04/26/2024 08:53 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ZyVersa Therapeutics (NASDAQ:ZVSA)CurrentInstitutional OwnershipPercentage3.91%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$10.34MNumber ofInstitutional Sellers(last 12 months)0 Get ZVSA Insider Trade Alerts Want to know when executives and insiders are buying or selling ZyVersa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy ZyVersa Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/27/2023Virtu Financial LLC120,377$30K0.0%N/A0.595% 4/17/2023 Winthrop Advisory Group LLC13,361$26K0.0%N/A0.145% (Data available from 1/1/2016 forward) ZVSA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZVSA shares? During the previous two years, the following institutional investors and hedge funds held shares of ZyVersa Therapeutics shares: Virtu Financial LLC ($30K), Winthrop Advisory Group LLC ($26K).Learn more on ZVSA's institutional investors. What percentage of ZyVersa Therapeutics stock is owned by institutional investors? 3.91% of ZyVersa Therapeutics stock is owned by institutional investors. Learn more on ZVSA's institutional investor holdings. Which institutional investors have been buying ZyVersa Therapeutics stock? The following institutional investors have purchased ZyVersa Therapeutics stock in the last 24 months: Virtu Financial LLC ($120.38K), and Winthrop Advisory Group LLC ($13.36K). How much institutional buying is happening at ZyVersa Therapeutics? Institutional investors have bought a total of 133,738 shares in the last 24 months. This purchase volume represents approximately $19.37M in transactions. Related Companies: CING Major Shareholders GNPX Major Shareholders SNGX Major Shareholders SEEL Major Shareholders ENSC Major Shareholders LGVN Major Shareholders PCSA Major Shareholders XCUR Major Shareholders PTPI Major Shareholders NEXI Major Shareholders This page (NASDAQ:ZVSA) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
